TH96108B - Pharmaceutical components that contain 3 '- ((2Z) - (1- (3,4-dimethylphenyl) -1,5-dihydrochro-3-methyl-5-oxho-4H-pyrazol -4-illydine] hydrazino] -2'-hydroxy- [1,1'-biphenyl] -3-carboxylic acidbis- (mono A Tthanolamine) - Google Patents

Pharmaceutical components that contain 3 '- ((2Z) - (1- (3,4-dimethylphenyl) -1,5-dihydrochro-3-methyl-5-oxho-4H-pyrazol -4-illydine] hydrazino] -2'-hydroxy- [1,1'-biphenyl] -3-carboxylic acidbis- (mono A Tthanolamine)

Info

Publication number
TH96108B
TH96108B TH701003817A TH0701003817A TH96108B TH 96108 B TH96108 B TH 96108B TH 701003817 A TH701003817 A TH 701003817A TH 0701003817 A TH0701003817 A TH 0701003817A TH 96108 B TH96108 B TH 96108B
Authority
TH
Thailand
Prior art keywords
pyrazol
biphenyl
methyl
dimethylphenyl
hydroxy
Prior art date
Application number
TH701003817A
Other languages
Thai (th)
Other versions
TH96108A (en
Inventor
นายชิวากุมาร์ จี กาป์ไซ นายฟรานซิส เอ็กซ์ มุลเลอร์
Original Assignee
แกล๊กโซสมิธไคลน์ แอลแอลซี
Filing date
Publication date
Application filed by แกล๊กโซสมิธไคลน์ แอลแอลซี filed Critical แกล๊กโซสมิธไคลน์ แอลแอลซี
Publication of TH96108A publication Critical patent/TH96108A/en
Publication of TH96108B publication Critical patent/TH96108B/en

Links

Abstract

ที่เปิดเผยเป็นองค์ประกอบทางเภสัชกรรมรูปแบบใหม่ที่มี 3'-[(2Z)-[1-(3,4-ไดเม ทธิลฟีนิล)-1,5-ไดไฮโดร-3-เมทธิล-5-ออกโซ-4H-ไพราซอล-4-อิลลีดีน]ไฮดราซิโน]-2'-ไฮดรอกซี- [1,1'ไบฟีนิล]-3-คาร์บอกซิลิกแอซิดบิส-(โมโนเอทธาโนลามีน) (เอลตรอมโบแพกโอลามีน) และ กระบวนการสำหรับการเตรียมสารดังกล่าว Disclosed is a new form of pharmaceutical component with 3 '- ((2Z) - (1- (3,4-Dimé Tthylphenyl) -1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-illedene] hydracino] -2'-hydroxyl Oxy- [1,1 'biphenyl] -3-carboxylic acid bis- (monoethanolamine) (eltrombopagolamine) and Process for the preparation of such substances

Claims (1)

1. เม็ดยาทางเภสัชกรรมที่ประกอบอย่างเป็นสำคัญด้วย a)ปริมาณของ 3'-[(2Z)-[1-(3,4-ไดเมทธิลฟีนิล)-1,5-ไดไฮโดร-3-เมทธิล-5-ออกโซ-4H- ไพราซอล-4-อิลลีดีน]ไฮดราซิโน]-2'-ไฮดรอกซี-[1,1'-ไบฟีนิล]-3-คาร์บอกซิลิกแอซิดบิส-(โมโน- เอทธาโนลามีน)(3'[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4- ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanol1.Pharmaceutical tablet composed primarily with a) dosage of 3 '- ((2Z) - (1- (3,4-dimethylphenyl) -1,5-dihydro-3-). Methyl-5-oxo-4H-pyrazol-4-illedene] hydracino] -2'-hydroxy- [1,1'-biphenyl] -3- Carboxylic acid bis - (mono-ethanolamine) (3 '((2Z) - (1- (3,4-dimethylphenyl) -1,5-dihydro-3-) methyl-5-oxo-4H-pyrazol-4- ylidene] hydrazino] -2'-hydroxy- [1,1'-biphenyl] -3-carboxylic acid bis- (monoethanol
TH701003817A 2007-08-01 Pharmaceutical components that contain 3 '- ((2Z) - (1- (3,4-dimethylphenyl) -1,5-dihydrochro-3-methyl-5-oxho-4H-pyrazol -4-illydine] hydrazino] -2'-hydroxy- [1,1'-biphenyl] -3-carboxylic acidbis- (mono A Tthanolamine) TH96108B (en)

Publications (2)

Publication Number Publication Date
TH96108A TH96108A (en) 2009-06-18
TH96108B true TH96108B (en) 2009-06-18

Family

ID=

Similar Documents

Publication Publication Date Title
FI3090730T3 (en) TABLETS CONTAINING ELTROMBOPAGIOLAMINE
BRPI0310094B8 (en) 3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene] acid bis(monoethanolamine) compound hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid, pharmaceutical composition and processes for preparing said compound and pharmaceutical composition
WO2008109180A3 (en) Metalloprotease inhibitors containing a heterocyclic moiety
HRP20120004T1 (en) Dipeptidyl peptidase inhibitors for treating diabetes
UY32062A (en) BETA-SECRETASA INHIBITORS
WO2007139856A3 (en) Heterobicyclic metalloprotease inhibitors
AR058433A1 (en) DERIVATIVE OF 1,1-DIOXIDE OF 1,4-BENZOTIAZEPIN, PROCEDURE FOR PREPARATION, MEDICATIONS UNDERSTANDING THIS COMPOSITE AND ITS USE
AR052270A1 (en) PROCEDURE TO COMBAT FUNGICAL DISEASES IN LEGUMINOUS
WO2004055006A8 (en) Novel compounds having selective inhibiting effect at gsk3
NI200900021A (en) KINASE INHIBITOR
AR113778A2 (en) PHARMACEUTICAL COMPOSITION THAT COMPRISES A DIPHOSPHATE SALT OF N-[6-(CIS-2,6-DIMETHYLMORFOLIN-4-IL)PYRIDIN-3-IL]-2-METHYL-4'-(TRIFLUORMETHOXY)[1,1'- BIPHENYL]-3-CARBOXAMIDE
AR059357A1 (en) PHARMACEUTICAL FORMULATIONS
ECSP045493A (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLIBANSERINE POLYMORPH A
AR088497A1 (en) PHARMACEUTICAL COMPOSITIONS OF COMBINATIONS OF INHIBITORS OF DIPEPTIDIL PEPTIDASE 4 WITH ATORVASTATIN
AR049681A1 (en) MACROLIDS PREPARED FROM ACTINOMICETS. PHARMACEUTICAL COMPOSITIONS
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
MXPA02010828A (en) Pharmaceutical composition in capsules comprising a non-steroidal anti-inflammatory and an opiate analgesic for handling pain.
ITFI20030070A1 (en) STABILIZED TOPICAL FORMULATIONS CONTAINING KETOPROFENE
AR057885A1 (en) ACID 1- (1- (2- ETOXIETIL) - 1- ETIL-7- (4- METHYLPIRIDIN -2- ILAMINO) - 1H PIRAZOLO (4,3-D) PIRIMIDIN -5- IL) PIPERIDINE -4- CARBOXYL AND SALTS OF THE SAME. PHARMACEUTICAL COMPOSITIONS.
EA200300692A1 (en) ANTI-INFLAMMATORY AND ANTI-INFLAMMATORY COMPOSITIONS CONTAINING CYCLOOXIGASE-2 INHIBITORS
CO5700723A2 (en) USE OF A SPECIFIC CYCLIC AMINE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS TO TREAT AND PREVENT CARDIAC INSUFFICIENCY
EA201000882A1 (en) COMPOUND, ITS APPLICATION AND PHARMACEUTICAL COMPOSITION CONTAINING THIS COMPOUND
TH96108A (en) Pharmaceutical components that contain 3 '- ((2Z) - (1- (3,4-dimethylphenyl) -1,5-dihydro-3-methyl-5-oxo-4H-pyrazol- 4- illydine] hydrazino] -2'-hydroxy- [1,1'-biphenyl] -3-carboxylic acidbis- (monoate Thanolamine)
EA200801137A1 (en) COMPOUNDS FOR INHIBITING APOPTOSIS
AR089710A1 (en) STABILIZED PHARMACEUTICAL COMPOSITIONS OF A HEPATITIS C VIRUS INHIBITOR